A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic Cancer

Clinical trial NCT06644170 · COMPLETED

Trial details

NCT number: NCT06644170
Sponsor: University of Washington
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematopoietic and Lymphatic System Neoplasm Metastatic Malignant Solid Neoplasm

Start date: 2024-11-19
Primary completion: 2025-09-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.